Bispecific Antibodies in Lymphoma
Tune in, as we dive into bispecific antibodies, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Also discussed are side effects, management strategies, and emerging trends in bispecific therapies. To access free Healthcare Professional accredited CME/CE continuing education activities, podcasts, and resources, please visit https://www.LLS.org/CE.
▶︎
Treating Lymphoma with Bispecific Antibodies | LRF Webinars
▶︎
What’s New and What’s Next in CLL
▶︎
Bi-and tri-specific antibodies in non-Hodgkin Lymphoma: current data and perspectives
▶︎
Understanding MRD for HCPs
▶︎
Lymphoma - symptoms, diagnosis and GP questions
▶︎
James Wells describes his battle with AML
▶︎
What are bispecific antibodies? #myeloma
▶︎
A Hospice Nurse Explains How to Prepare for a Better End of Life Scenario
▶︎
Improving Outcomes in Hairy Cell Leukemia
▶︎
Update on Bispecific Antibodies | Lymphoma Research Foundation Webinars
▶︎
Managing CML: What HCPs Need to Know
▶︎
An overview of lymphoma with Dr Rob Lown
▶︎
Doctors break down every stage of lymphoma | Cancer: Explained | Macmillan Cancer Support
▶︎
What are bispecific antibodies?
▶︎
117. You Already Measure: Turning Objective Findings into Growth
▶︎
Advancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligibility, and Awareness
▶︎
Delivering Equitable Cancer Care
▶︎
Optimizing Outcomes in Myeloma
▶︎
Leukemia: Alternative Treatment
▶︎